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biw.kuleuven.be)Continuous reports on foodborne outbreaks and increasing
prevalence of antibiotic-resistant bacteria call for the develop-
ment of novel preservation techniques that assure the safety of
food products. Bacteriophage endolysins are highly active an-
tibacterial peptidoglycan hydrolases that have evolved over
millions of years to become the ultimate weapon against bac-
teria, with potential to be used as a food preservative. We here
give an overview of all distinct endolysins encountered so far,
we discuss their inherent qualities and review their role in pre-
venting and controlling foodborne pathogens, divulging their
potential for future applications.Introduction
With a continuous increase of bacterial foodborne out-
breaks and corresponding costs (FDA, 2009), maintainingour food quality at an elevated level is of extreme social
and economic importance. With 9.4 million foodborne ac-
quired illnesses on a yearly basis in the United States alone,
control of foodborne outbreaks has become a vital issue in
the last decade (Scallan et al., 2011). In addition, the grow-
ing amount of antibiotic-resistant strains is placing patients
even more at risk. The increasing consumer awareness has
resulted in higher demands for safe food, leading industries
to develop more modern production technologies, good
manufacturing practices, quality control and hygiene and
safety models (such as risk assessment, HACCP and
“farm to fork” concepts).
According to several food regulatory entities the com-
mon microorganisms that cause foodborne diseases are
Salmonella, Escherichia coli O157:H7, Campylobacter
and Listeria, alongside other, less common infectious spe-
cies (CDC, 2011; EFSA, 2009). Interestingly, the introduc-
tion of chemical preservatives to increase food safety has
raised public concern, in part due to the potential risk asso-
ciated with some of these compounds. Therefore, focus has
been directed to more natural antimicrobial alternatives,
such as endolysins.
Endolysins (or lysins) are bacteriophage-encoded lytic
enzymes that break down the peptidoglycan of the bacterial
cell wall during the terminal stage of the bacteriophage re-
production cycle. These enzymes compromise the mechan-
ical strength and resistance of the cell wall that is needed to
withstand the internal cytoplasmic turgor (osmotic) pres-
sure, causing bacteriolysis and the subsequent release of
the bacteriophage progeny.
A food antimicrobial should have a selective mode of
action, should not change the organoleptic characteristics
and texture properties of the food product, and should be
an innocuous substance for human consumption. Lysins
meet all these requirements and therefore seem to be
good candidates for the control of foodborne pathogens.
The biotechnological potential of these intriguing en-
zymes has been discussed previously (Fischetti, 2005b,
2010; Hermoso, Garcia, & Garcia, 2007; Loessner, 2005),
however only few have taken on a food-based perspective
(Callewaert, Walmagh, Michiels, & Lavigne, 2011).
This review covers key concepts of phage lysin biology, as
well as the endolysinehost interactions. It summarizes the en-
dolysin characteristics that are important for efficient food bi-
opreservation and discusses them, in order to allow for a better
understanding of their potential as a pathogenic control agent.
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Enzymatic function and substrate recognition on the
peptidoglycan network
The rigid peptidoglycan (PGN) layer is responsible for
bacterial physical integrity and shape. It is composed of
several chains of alternating residues of N-acetylmuramic
acid (MurNAc) and N-acetylglucosamine (GlcNAc), con-
nected by b-1,4 glycosidic bonds, linked to a short stem tet-
rapeptide (Donovan, Dong, et al., 2006). Whereas the
carbohydrate backbone is conserved in all bacteria, the pep-
tide moiety made of L- and D-amino acids is only conserved
in Gram-negative organisms. In Gram-positives, it is con-
siderably more diverse in terms of length and composition.
The amino acid residue in position 3 defines two types of
PGN: a meso-2,6-diaminopimelic acid type (mDAP-type)
in Gram-negative and some Gram-positive species (i.e.
Bacillus and Listeria spp.) and an L-lysine type (Lys-type)
typical for Gram-positive organisms. In the mDAP-type
the peptide stem is usually directly linked via an amide
bond, while in the Lys-type they are connected through
an interpeptide bridge, such as in pentaglycine (Staphylo-
coccus aureus) or dialanine (Streptococcus pyogenes)
(Fig. 1).
Bacteriophages (or phages) are viruses that specifically
infect bacteria. Lacking an independent replication system,
they highjack the host’s DNA replication and protein syn-
thesis machinery. After replication inside the host, phages
are faced with the degradation of the cell wall to release
their progeny. To overcome the PGN integrity, most dsDNA
phages contain a holineendolysin based system. Endoly-
sins are enzymes that break down the PGN, however theyFig. 1. Schematic representation of the main PGN differences (in bold) betwe
of action according to their murein activity: 1) N-acetyl-b-D-glucosaminidase;
amoyl-L-alanine amidase; 5) L-alanoyl-D-glutamate endopeptidase; 6) D-alan
8) D-glutamyl-m-DAP endopeptidase (no endolygenerally do not contain signal peptides to direct them to-
ward their substrate. For this to happen, a second hydropho-
bic membrane-spanning protein e holin e is needed.
Holins are responsible for the formation of cytoplasmic
membrane patches (Loessner, 2005; Wang, Smith, &
Young, 2000) through which endolysins can get access to
the murein layer. Endolysins cleave this layer, until the
cell loses its capacity to withstand the internal osmotic
pressure, ultimately resulting in hypotonic cell lysis. In
order to induce cell lysis, endolysins must perform two ba-
sic functions: substrate recognition and enzymatic hydroly-
sis. Endolysins have evolved over millions of years to
recognize various ligands within the cell envelope. Yet,
due to the well-conserved overall structure of the PGN
they are limited in their nature. Depending on their catalytic
activity and the bonds that they hydrolyze, endolysins can
be divided into different classes (Fig. 1).
Glycosidases cleave the glycan component at the reduc-
ing end of GlcNAc (Fig. 1, target 1), as shown for the strep-
tococcal LambdaSa2 lysin (Pritchard, Dong, Kirk, Cartee,
& Baker, 2007), or at the reducing end of MurNAc
(Fig. 1, target 2), as described for the streptococcal B30
lysin (Pritchard, Dong, Baker, & Engler, 2004). The N-ace-
tyl-b-D-muramidases (often called lysozymes or murami-
dases) share the same glycan target as the lytic
transglycosidases (Fig. 1, target 3), however both deliver
different end products: transglycosidases do not work as
genuine hydrolases since no water is involved in the cleav-
age of the glycoside bond, and a 1,6-anhydro bond is
formed instead in the muramic acid residue (Vollmer,
Joris, Charlier, & Foster, 2008). This is the rarest classen a Gram-positive and Gram-negative bacterium and endolysin mode
2) N-acetyl-b-D-muramidase; 3) lytic transglycosylase; 4) N-acetylmur-
yl-glycyl endopeptidase; 7) D-alanine-D-meso-DAP endopeptidase and
sin has been reported for class 7 and 8).
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aeruginosa phage phiKZ gp144 lysin (Fokine,
Miroshnikov, Shneider, Mesyanzhinov, & Rossmann,
2008). Distinct classes of amidases catalyze the hydrolysis
of the critical amide bond between MurNAc and the L-ala-
nine (Fig. 1, target 4), separating the glycan strand from the
stem peptide. Therefore, amidases are predicted to cause
the strongest destabilization effect in the PGN. In addition,
distinct classes of endopeptidases and carboxypeptidases
attack the LD- and DD-bonds in the stem peptides, as has
been demonstrated for Listeria Ply500 and the Ply118 L-al-
anyl-D-glutamate endopeptidases (Loessner, Wendlinger, &
Scherer, 1995) (Fig. 1, target 5). Other endopeptidases, like
the staphylococcal phi11 D-alanyl-glycyl endopeptidase,
also cleave within peptides that crosslink the cell wall
(Navarre, Ton-That, Faull, & Schneewind, 1999) (Fig. 2,
target 6). The muramidase and amidase groups target the
most conserved bonds in the PGN and seem to be the
most widely spread (Fischetti, 2008).
As a result of their different enzymatic functions, the
lytic spectrum of Gram-positive phage endolysins is con-
sidered to be limited to the bacterial species from which
the phage is derived. Examples of such restricted activity
have been reported for the pneumococcal bacteriophageFig. 2. Overview of different reported molecular structures for endolysins. A
B. Bimodular structure with N-terminal ECD and a C-terminal CBD; C. Tri
D. Trimodular structure with three ECDs; E. Multimeric structure composed
enzyme, typical in Gram-negative endolysins) G. Bimodular structure with
two N-terminal CBDs and a C-terminal ECD. Abbreviations: ECD, enzym
Briers, Volckaert, elytic enzyme Pa (Loeffler, Nelson, & Fischetti, 2001) and
the Bacillus anthracis phage endolysin PlyG (Schuch,
Nelson, & Fischetti, 2002). Furthermore, the Staphylococ-
cus bacteriophage endolysin LysH5 only leads to lysis of
S. aureus and Staphylococcus epidermidis (Obeso,
Martinez, Rodriguez, & Garcia, 2008) and is not active
against several lactic acid bacteria and strains belonging
to Bacillus, Streptococcus, Clostridium, Listeria, and
Enterococcus spp., as expected due to their low degree of
PGN homology. The pneumococcal phage endolysin Cpl-
1 recognizes choline decorations on teichoic acids, result-
ing in a very narrow activity spectrum (Perez-Dorado
et al., 2007). Nevertheless, endolysins with a broader lytic
spectrum can also be found. An example is PlyV12, pro-
duced by the Enterococcal bacteriophage phi1. This endo-
lysin displays activity on 14 Enterococcus faecalis and
Enterococcus faecium strains, on pathogenic streptococci,
including S. pyogenes (Group A, B and C) and on S. aureus
strains (Yoong, Schuch, Nelson, & Fischetti, 2004). Endo-
lysin Lyb5, from the Lactobacillus fermentum temperate
bacteriophage phiPYB5, exhibits activity on both Gram-
positive (S. aureus, Bacillus subtilis and several lactic
acid bacteria) and Gram-negative bacteria (e.g. E. coli
and Salmonella typhimurium) (Wang, Kong, & Zhang,. ECD only (globular enzyme, atypical in Gram-positive endolysins);
modular structure with two N-terminal ECDs and a C-terminal CBD;
of a single heavy chain and eight light chains; F. ECD only (globular
N-terminal CBD and a C-terminal ECD; H. Trimodular structure with
e catalytic domain; CBD, cell wall binding domain. Adapted from
t al. (2009).
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endolysin Mur-LH is active on several lactic acid bacteria,
but also on more distant species like B. subtilis, E. faecium
and Pediococcus acidilactici (Deutsch, Guezenec, Piot,
Foster, & Lortal, 2004). Amidase classes of endolysins
may represent a broader lytic spectrum compared to other
classes, since the amide bond between the N-acetylmur-
amic acid residue and L-alanine is conserved among several
bacterial species (Navarre et al., 1999).
Finally, we note that thus far only a few endolysins have
been identified that are able to degrade pseudomurein, the
peptidoglycan component of methanogenic archaea. To
date, no enzymes have been found that can cleave the
b-1,3 glycosidic bond of pseudomurein, and only two en-
doisopeptidases, PeiW from the methanogenic prophage
Methanothermobacter wolfeii psiM100 and PeiP from
Methanothermobacter marburgensis psiM2, have been
identified that cleave between the ε-amino group of L-lysine
and the carboxyl group of an L-alanine residue within pseu-
domurein (Visweswaran, Dijkstra, & Kok, 2010).
Natural molecular structures inherited
Depending on their origin, endolysins can vary in their
molecular structure, either modular or globular, and in their
domain orientations. An illustration of all molecular ar-
rangements encountered so far is represented in Fig. 2.
Gram-positive endolysins possess a typical, well-defined
modular architecture, with an enzymatic catalytic domain
(ECD) at the N-terminal and a cell wall binding domain
(CBD) at the C-terminal end, separated by a short linker
(Fischetti, 2008; Loessner, 2005). While the ECD is re-
sponsible for the cleavage of the bonds in the PGN of the
bacterial cell wall, the CBD confers specificity in substrate
recognition and subsequent binding to the cell wall. Some
endolysins have even acquired more than one independent
ECD, such as the endopeptidase/muramidase from the
Streptococcus agalactiae bacteriophage B30 (Pritchard
et al., 2004), the muramidase/endopeptidase of a pneumo-
coccal phage Cpl-1 lytic enzyme (Hermoso et al., 2003),
the endopeptidase/amidase of the phage phi11 lysin
(Navarre et al., 1999) and the endopeptidase/glucoamidase
of a streptococcal LambdaSa2 lysin (Donovan & Foster-
Frey, 2008). However, the presence of two catalytic
domains does not necessarily mean that they are equally ac-
tive: the D-glutaminyl-L-lysine endopeptidase of the strepto-
coccal lambdaSa2 was found to be responsible for almost
the entire hydrolytic activity of the protein (Donovan &
Foster-Frey, 2008).
The presence of three ECDs has only been described for
the staphylococcal phage187 lysin (Ply187), which harbors
an endopeptidase, an amidase and a glucosaminidase mod-
ule. However, not all lytic activities were experimentally
demonstrated (Cheng, Nelson, Zhu, & Fischetti, 2005).
The acquisition of such an organization has probably
evolved in order to adapt to changes in environmental con-
ditions. Besides endolysins with a modular organization,globular proteins with a single ECD also occur (e.g. T4
lysozyme (Matthews & Remington, 1974)). Another inter-
esting example is the streptococcal C1 bacteriophage lysin.
While in general endolysins have a molecular mass of
25e40 kDa (Fischetti, 2008), this unique lysin weighs
114 kDa. It is a multimeric PlyC that consists of one heavy
chain representing the catalytic site (PlyCA), and eight
PlyCB chains that bind the cell wall (Nelson, Schuch,
Chahales, Zhu, & Fischetti, 2006). Comparison of the
amino acid sequences of Gram-positive lytic enzymes of
the same enzyme class reveals high homology within the
N-terminal catalytic region and very little homology within
the C-terminal cell binding region.
In contrast to their Gram-positive counterparts, endoly-
sins active against Gram-negatives generally display a glob-
ular structure (i.e. only contain the ECD) and rarely show
a modular organization. With no exceptions, the few endo-
lysins with a modular structure all have inverted molecular
orientations compared to Gram-positive endolysins, with
the ECD at the C-terminal and the CBD at the N-terminal
side (e.g. KZ144 of phiKZ (Briers et al., 2007)). An even
more unusual endolysin is OBPgp279, belonging to the
Pseudomonas putida phage OBP, which is predicted to
have two CBDs (Cornelissen et al., 2011). While it is
shown that CBDs of endolysins targeting Gram-positives
enhance the substrate affinity of the enzyme, those found
in Gram-negatives, like endolysin KZ144 and EL188,
show a broad binding spectrum (Briers et al., 2007).
The fact that CBDs only occur in endolysins of Gram-
positive origin and not in their Gram-negative counterparts
may have an evolutionary explanation. The PGN in Gram-
positive bacteria is exposed to the surface. If enzymes de-
prived of a CBD spill out after cell lysis, they would
have a good chance of killing surrounding bacteria before
the progeny phage particles could start a new infection cy-
cle (Fischetti, 2008). Subsequently, it is believed that these
enzymes have evolved to bind irreversibly to their cell wall
ligand by means of a CBD, so that they are not released af-
ter cleavage of the target site (Loessner, Kramer, Ebel, &
Scherer, 2002). Converging with this is the theoretical cat-
alytic capacity of a single enzyme to cleave enough bonds
to kill an organism and the extremely high, nanomolar
range, affinity of their CBDs (Loessner et al., 2002). This
suggests that they are single-use enzymes only. Such phe-
nomenon would drive phages to produce endolysins in
just the right amount to lyse the cell. In contrast to
Gram-positive bacteria, Gram-negative cells are resistant
to external lysin treatment (“lysis from without”), due to
their protective outer membrane. As such, there is no evo-
lutionary pressure to acquire CBDs, making the observation
of the few modular endolysins from Gram-negative infect-
ing phages extremely interesting. More specifically, the few
modular endolysins active against Gram-negatives were
isolated from the P. aeruginosa phages phiKZ and EL,
P. putida phage OBP (with genome sizes of 280 kb,
211 kb, and 207 kb, respectively) (Cornelissen et al.,
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(Thomas et al., 2008), Salmonella enteritidis phage
PVPSE1 (145 kb) (Santos et al., 2011) and Campylobacter
coli phage phiCcoIBB35 (204 kb, not published), all be-
longing to the Myoviridae family. These data suggest that
this rare modular organization might be restricted to
Myoviridae giant phages.
Endolysin architectural structure engineered
The compelling need to develop even more efficient en-
dolysins, and the relative independence of the modular do-
mains within endolysins, has led to the creation of new
hybrid enzymes. In this approach, the emphasis is laid on
adding, truncating or swapping endolysin domains to obtain
enzymes with optimized applications. A handful of studies
have used this strategy with the aim to increase the speci-
ficity or efficiency of endolysin activity. Pioneer work fo-
cused on exchanging catalytic domains of a Streptococcus
pneumoniae phage lysin, which resulted in endolysins
with the same binding characteristics but with multiple
PGN targets (Garcia, Garcia, Garcia, Sanchez-Puelles, &
Lopez, 1990). Since then, other studies have followed by
using the same proof of principle, as for instance with the
pneumococcal phage CPL1 lysozyme (Diaz, Lopez, &
Garcia, 1990). The Staphylococcal P16 endolysin was
modified in a similar way to overcome insolubility prob-
lems (Manoharadas, Witte, & Blasi, 2009). For Gram-
positive endolysins, structural engineering has resulted in
mixed successes. For instance, CBD truncation of the endo-
lysins Ply118 and Ply500 (Loessner et al., 2002) or the
Clostridium perfringens bacteriophage phi3626 lysin
(Zimmer, Vukov, Scherer, & Loessner, 2002) abolished an-
tibacterial activity, while for the Mur endolysin lytic activ-
ity remained unaltered (Vasala, Valkkila, Caldentey, &
Alatossava, 1995). In other studies higher bacteriolytic ac-
tivity was achieved (Gaeng, Scherer, Neve, & Loessner,
2000; Loessner, Gaeng, & Scherer, 1999; Loessner,
Gaeng, Wendlinger, Maier, & Scherer, 1998; Low, Yang,
Perego, Osterman, & Liddington, 2005) and in the case
of the CBD-truncated LysK and PlyGBS lysins a 2-fold
and approximately 25-fold increase in muralytic activity
was attained, respectively (Cheng & Fischetti, 2007;
Horgan et al., 2009). Innovative work on the detection of
biological weapons has been carried out, using the high af-
finity and sensitivity of a CBD of a gamma-phage lysin
(B. anthracis, the causative agent of anthrax) (Fujinami,
Hirai, Sakai, Yoshino, & Yasuda, 2007). Similarly, CBDs
were applied to bind and capture pathogens present in
food samples (Fujinami et al., 2007; Kretzer et al., 2007).
Interestingly, complete CBD sequences are not always
needed for this purpose, as a 10 amino-acid motif of the
phage lysin PlyG CBD was shown to be sufficient for the
specific detection of B. anthracis, when coupled to fluores-
cent quantum dots (Sainathrao, Mohan, & Atreya, 2009).
At least two modular endolysins were demonstrated to
be active against Gram-negative bacteria in the absenceof their N-terminal CBDs (Walmagh, Briers, Santos,
Azeredo, & Lavigne, 2012). Interestingly, despite that
CBDs are responsible for targeting the bacterial cell wall,
they do not always seem to be essential for endolysin anti-
bacterial activity. This finding has been observed for both
Gram-positive and Gram-negative bacteria, but awaits a mo-
lecular explanation. The currently described modular endo-
lysins, active against Gram-negative bacteria, have all
presented a wide lytic spectrum range (Briers et al.,
2007). This suggests a lack of bacterial specificity in con-
trast to their Gram-positive counterparts. However, their
CBDs can still be applied as permeabilizing biomarkers,
when fused to marker proteins such as fluorescent proteins,
to access the Gram-negative outer membrane (Briers,
Schmelcher, et al., 2009; Briers, Volckaert, & Lavigne,
2009).
Phage lysins in food biotechnology
Endolysin features for food safety applications
Foodborne diseases are an increasing matter of concern,
especially in view of the alarming emergence of antibiotic-
resistant bacterial strains. Therefore, attention has been
drawn to bacteriophage therapy as alternative bacteriolytic
agents to synthetic antimicrobials. Recently, two commercial
bacteriophage cocktails that battle Listeriosis, Listex P100
(Micreos) and ListShield (Intralytix), have received FDA ap-
proval (Shuren, 2006). However, in Europe it remains uncer-
tain whether phages can be considered as processing aids or
as decontaminants/additives (Teufer & Von Jagow, 2007). In
addition, the need to select virulent phage to avoid
transduction, the threshold requirements of the host and the
potential development of bacterial strains resistant to phages
are the main obstacles when considering phage as an antimi-
crobial for the food industry. Phage endolysins lack such dis-
advantages and therefore represent a promising alternative
for controlling foodborne pathogens.
Before considering the application of phage lysins as
a means to control foodborne diseases, an analysis of their
stability on food products and food processing facilities
should be considered, alongside other aspects concerning
consumer safety. Biocontrol agents need to withstand all as-
pects encountered in the foodborne matrix, such as stability
under the physiochemical conditions in which they are ap-
plied. They should be commercially attractive to consider
investment, and finally, they should be allowed as a biocon-
trol product by the international food regulatory agencies
and accepted by the consumer.
Host specificity
Endolysins only cleave PGN linkages that are exclu-
sively present in bacteria; however by displaying dissimilar
lytic spectra they can be exploited differently. When a wide
range of bacteria has to be controlled, endolysins with
a broad host range will be required. For instance, in agricul-
ture, endolysins targeting different bacterial taxa could play
an important role as biopesticides, preventing tomato scabs,
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michiganensis and Xanthomonas campestris, respectively.
In milk processing plants, endolysins could act as food san-
itizers targeting thermoduric bacteria (e.g. Bacillus spp. and
Paenibacillus spp.) and psychrotolerant Pseudomonas spp.,
preventing spoilage of pasteurized milk and extending the
shelf-life of food products.
Endolysins with a narrower range of action, targeting
a specific or at least closely related bacterial species or
genus, could prove useful for the elimination or control
of specific pathogens or spoilage organisms. In livestock,
endolysin e prebiotic e products could be administered
to control enteric diseases in the cattle and poultry
gastro-intestinal tract (e.g. with C. perfringens Ply2626 ly-
sin on poultry), while leaving the gut microflora unaltered
(Zimmer et al., 2002). Alternatively, endolysins can control
mastitis-causing bacteria in mammary glands of dairy cattle
(e.g. with Streptococcus uberis Ply700 and S. aureus LysH5
endolysins) (Celia, Nelson, & Kerr, 2008; Obeso et al.,
2008), preventing cross-contamination of food during milk-
ing and slaughtering procedures. In industrial fermenta-
tions, endolysins like Ply511 could be secreted in situ in
modified starter cultures, to control Listeria monocytogenes
spoilage in milk (Gaeng et al., 2000), or added as a food
additive, like the clostridial-specific CTP1 lysin preventing
cheese spoilage and blowing (Mayer, Payne, Gasson, &
Narbad, 2010).
Temperature
The effect of thermal stress on endolysins can be vari-
able. It is important to determine their antimicrobial activ-
ity under the different temperatures that can be found in
food systems (e.g. chilled food of approximately 4 C) to
allow for efficient biocontrol. Surprisingly, endolysins
have been shown to perform at a wide temperature range.
While the bacteriophage T4 lysozyme retains only a minor
fraction of its activity after a 5 min treatment at 65 C
(Nakagawa, Arisaka, & Ishii, 1985), KZ144 and EL188 en-
dolysin activity remains high even when exposed for
10 min to 50 C (Briers et al., 2007). Others are shown
to be stable for 30 min at 45 C (Loeffler, Djurkovic, &
Fischetti, 2003), or exhibit only a 30% decrease in activity
when exposed for 30 min to 90 C (Schmelcher, Waldherr,
& Loessner, 2011). Even higher thermostability has been
described for the lysozyme domain of gp36 from a P. aer-
uginosa phage phiKMV, which is resistant to temperatures
up to 100 C (Lavigne, Briers, Hertveldt, Robben, &
Volckaert, 2004). However, it is likely that phages isolated
from more thermostable bacteria will contain endolysins
that are even more thermostable. Good examples of sources
of potentially thermostable endolysins are Bacillus phage
W1 and Geobacillus phage E1, isolated from deep-sea ther-
mophilic bacteria, or the bacteriophage phiTMA isolated
from the extreme thermophile Thermus thermophilus, orig-
inating from hot springs (Liu, Wu, Song, Zhang, & Xie,
2006; Tamakoshi et al., 2011). Endorsing this hypothesisis the characterized Thermus aquaticus phage phiIN93
endolysin with an optimal activity between 60 and
120 C (Matsushita & Yanase, 2008). Some bacteria,
such as Listeria spp., are able to multiply even in refriger-
ated conditions. However, little is known about endolysin
activity on this side of the temperature spectrum. Activity
at temperatures as low as 2 C has been described for the
bacteriophage phiLM4 lysin (Gasson, 1992). Recently, an
endolysin LysZ5 report showed the ability to reduce Liste-
ria contamination at 4 C on soya milk (Zhang, Bao,
Billington, Hudson, & Wang, 2012). It is therefore esti-
mated that with further phage characterization, novel
thermo- and cryo-resistant endolysins will be identified
and new potential food applications that require thermal
processing will be established.
pH tolerance
Phage lysin studies have indicated that their optimum
pH usually lies within the range of 4.0e6.0 (Borysowski,
Weber-Dabrowska, & Gorski, 2006). However, some lysins
retain significant antibacterial activity at pH 7.4 (blood pH)
(Fischetti, 2004; Jado et al., 2003; Loeffler et al., 2003). In
addition, the endolysin PlyPH, with a specific activity
against Bacillus cereus and B. anthracis strains, remains ac-
tive over an unusually broad pH range of 4e10.5 (Yoong,
Schuch, Nelson, & Fischetti, 2006).
Processing environments
Potential problems in food processing units associatedwith
bacterial biofilms e the formation of an aggregate of micro-
organisms as a result of bacterial surface adherence e can
be overcome by the use of endolysins. Despite the higher re-
sistance of biofilms to antimicrobials, compared to planktonic
cells, two staphylococcal phage lysins were shown to success-
fully hydrolyze staphylococcal biofilms (Sass & Bierbaum,
2007; Son et al., 2010).
On food environments, studies have demonstrated bacte-
rial elimination from food samples such as milk (with
a high content of lipids and proteins, and a pH ranging
from 6.4 to 6.8). In addition, endolysin activity has been
shown in the presence of nonionic detergents (i.e. hard wa-
ter and organic compounds). Furthermore, its potential as
an enzymatic disinfectant on surfaces has been investigated
(Hoopes et al., 2009), as well as its antimicrobial properties
(Donovan, Lardeo, & Foster-Frey, 2006; Garcia, Martinez,
Rodriguez, & Rodriguez, 2010). Still, enzyme stability
should be measured taking into account all possible enzyme
antagonists and catalytic toxic effects that can be encoun-
tered in all food matrices (e.g. proteolytic enzymes).
The use of non-thermal treatment approaches can be
synergistically used with bactericidal compounds to con-
tribute to food stabilization and shelf-life prolongation.
This was demonstrated when high hydrostatic pressure
(HHP) was combined with lysozymes in the inactivation
of the Gram-positive bacteria Listeria innocua and
S. aureus (Masschalck, Deckers, & Michiels, 2002). HHP
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tion by endolysins on Gram-negative bacteria. This
approach was proven to efficiently inactivate several
Gram-negative pathogens, without loss of enzyme activity
even when exposed to harsh treatment at 600 MPa and
60 C for 15 min (Briers et al., 2008; Masschalck, Van
Houdt, Haver, & Michiels, 2001; Nakimbugwe,
Masschalck, Atanassova, Zewdie-Bosuner, & Michiels,
2006). HHP can be applied as an alternative to heat pasteur-
ization, the more conventional food preservation technique.
It even allows a better retention of product properties be-
cause it can be applied at low temperatures. With the cur-
rent state of this technology, its use could be limited only
by financial inviability, as its implementation requires
high investment costs.Antimicrobial efficiency
The potent antimicrobial power of endolysins is notable.
Nanogram quantities were able to eliminate bacteria from
suspensions in seconds (Loeffler et al., 2001; Nelson,
Loomis, & Fischetti, 2001). In addition, affinity detection
methods using nanomolar amounts of CBDs have been de-
scribed (Loessner et al., 2002). To date, no other known bi-
ological compound has been found to kill microorganisms
this quickly. Even the lysis of dead cells has been reported
(Sonstein, Hammel, & Bondi, 1971), although this is con-
sidered highly unfavorable as it diverges the enzyme
away from the real target: living bacteria. A positive aspect
is the possibility to eradicate antibiotic-resistant bacteria, as
was shown on methicillin-resistant and multidrug-resistant
S. aureus (MRSA) strains (endolysin LysK and endolysin
MV-L, respectively) (O’Flaherty, Coffey, Meaney,
Fitzgerald, & Ross, 2005; Rashel et al., 2007), or
penicillin-resistant S. pneumoniae (Loeffler et al., 2001).
It was also shown to work well against E. faecalis and E.
faecium strains resistant to vancomycin (endolysin
PlyV12) (Yoong et al., 2004). To further improve the anti-
microbial efficacy, synergistic methods using an endolysin
cocktail or a combination with antibiotics can be employed
to eliminate bacteria less accessible to antibiotics. As a re-
sult, the emergence of lysin/antibiotic resistant mutants
would slow down. Consistent with this, antibiotic-
resistant S. pneumoniae strains have been targeted using
Cpl-1 and Pal lysins having the same target specificity,
but different catalytic activities in vitro (Loeffler &
Fischetti, 2003) and in vivo (Jado et al., 2003). Synergistic
effects between lysins and antibiotics have also been dem-
onstrated with the Cpl-1 bacteriophage lytic enzyme and
penicillin or gentamicin against S. pneumoniae strains
with different levels of susceptibilities to penicillin
(Djurkovic, Loeffler, & Fischetti, 2005). The staphylococ-
cal lysin MV-L was also used in combination with the gly-
copeptide antibiotics vancomycin or teicoplanin against the
vancomycin-intermediate S. aureus (VISA) (Rashel et al.,
2007).Long-term storage (shelf life)
A good food antimicrobial extends the shelf-life of food
products. Several endolysins demonstrate an extraordinarily
long-term stability, such as Cpl-1, which showed no loss in
activity over 6 months at 4 C and 3 weeks at 37 C
(Loeffler et al., 2003). Other examples of endolysins with
a long-term stability are KZ144 and EL188, which can be
stored for 4 months at 4 C while retaining full activity
(Briers et al., 2007) (see also sections Temperature and
pH tolerance for more information on factors determining
the endolysin’s shelf-life properties).
Costs
The production costs of endolysins are expected to be
high with the current technology, which may constitute
the most significant barrier to their application as an alter-
native to phages or antibiotics. However, in the food indus-
try, a cost-efficient production of enzymes should not be
considered an insurmountable obstacle, since a wide variety
of enzymes are commercially available and produced in kg
to ton quantities for application as enzyme supplements
(baking, brewing, cheese flavoring, etc.). Technological de-
velopments for more efficient expression systems would
make the option to use endolysins as food control agents
a financially appealing one. Also, in situ expression of nat-
ural antimicrobials such as endolysins in transgenic grains,
plant leaves, crops and even animals may eventually reduce
costs. For lysozymes all these scenarios have been success-
fully applied to prevent pathogenic contamination. For
phage endolysins however only expression in transgenic
potatoes and in starter cultures has been reported (During,
Porsch, Fladung, & Lorz, 1993; Gaeng et al., 2000). There-
fore, much work still remains to be done.
Avoidance and resistance
Repetitive exposure of bacteria grown on agar plates to
low concentrations of lysin did not lead to the recovery of
resistant strains; neither did bacterial resistance occur after
several cycles of exposure to low concentrations of enzyme
in liquid conditions (Loeffler et al., 2001). In contrast, sev-
eral antiviral mechanisms of bacteria against phages have
been described (Labrie, Samson, & Moineau, 2010). It
has been postulated that the lack of bacterial resistance
toward endolysins is due to their unique mode of action.
To avoid being trapped inside the host, phages have evolved
to produce enzymes such as endolysins, targeting essential
molecules that cannot be altered by bacteria. As a result,
bacterial resistance is rare (Fischetti, 2004, 2005a;
Loeffler et al., 2001). This is the case for the endolysins
of Pneumococcus phages that bind to choline, an amino al-
cohol present in PGN and indispensable for pneumococcal
viability (Fernandez-Tornero et al., 2005). Another exam-
ple is the action of an endolysin of the Streptococcus group
A phage that binds to polyrhamnose, which is a molecule
indispensable for the growth of these bacteria (Fischetti,
2003). To minimize the occurrence of resistance, a selection
Table 1. Factors affecting application in food-based methodolo-
gies.
< Process-related
 Low probability to develop resistance
 Both specific and broad activity spectrum
 Active under refrigerated conditions
(for chilled products)
 Efficacy for biofilm removal on food process
surfaces (e.g. on Gram-positive cells)
 Thermostability for thermal processing products
Effect
þ
þ
þ
þ
þ
< Food-related
 Susceptible for inactivation on food matrix
extreme pHs
 Sensitive to host-proteolytic activity
 Organoleptic characteristics remain unchanged
 Extend antimicrobial shelf-life
 Not self-replicating antimicrobial agent
 Efficient on antibiotic resistant pathogens
 Limited applications on Gram-negative pathogens


þ
þ

þ

< Food regulatory acceptance
 Apparent safe status (non-toxic)
 Not self-replicating antimicrobial agent
(better acceptance)
 Regulatory and consumer acceptance
þ
þ
þ/
< Economic/marketing impact
 Efficient antimicrobial (at nanoscale level)
 New mode of action (cleavage of PGN)
 Susceptible to protein engineering to achieve
better performance
 Relatively expensive to produce
þ
þ
þ

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be used, as was shown by the synergistic effect of two
phage lytic enzymes on penicillin-resistant S. pneumoniae
strains (Loeffler & Fischetti, 2003).
Consumer’s acceptance
The use of genetically modified organisms (GMOs) as
cell factories for endolysin production may raise public
concern, in case application in consumer products is envis-
aged. A survey in 2010 showed that the amount of con-
sumers that are very or extremely concerned about eating
GMO food marginally decreased (3%) compared to two
years before (Deloitte, 2010). GMOs have entered our lives
the last few decades, however European and American gov-
erning authorities have not yet managed to generalize leg-
islation regarding their use (Varzakas, Arvanitoyannis, &
Baltas, 2007). Regarding endolysins, this discussion applies
more to the use of GMOs as a whole and to what extent
GMOs and their “foreign” DNA can be spilled into the en-
vironment. Concerning the use of their translated end prod-
uct, endolysins can be considered as processing aids or as
food additives, in which case stringent tests to prove the ab-
sence of toxins, allergens, or other hazardous compounds
will determine their safety (Law, 2002). Several successful
preclinical treatments with endolysins have been carried
out in animal models and thus far no potential toxicity
was observed (Loeffler et al., 2003; McCullers,
Karlstrom, Iverson, Loeffler, & Fischetti, 2007).
Table 1 presents an overview of the main factors when
considering employing an endolysin food-based
methodology.
Application of phage lysins as biocontrol agents
Based on phage lysis specificity and host recognition,
several food applications have been stipulated to treat or
prevent spoilage. Several reports on the antimicrobial appli-
cation of endolysins along the food processing line have
been conducted, however much work remains to be done
(Table 2). On the primary commodities point of application,
secretion of the foreign T4 endolysin into the intercellular
spaces of transgenic potato plants effectively demonstrated
plant resistance to the phytopathogenic bacterium Erwinia
carotovora (During et al., 1993). Expression of the bacte-
riophage FEa1h endolysin resulted in growth inhibition of
Erwinia amylovora on pears (Kim, Salm, & Geider,
2004). S. aureus biocontrol in milk has been proposed by
expressing endolysins in transgenic cows (Donovan,
Lardeo, et al., 2006). Regarding S. aureus biofilm removal,
a proof of concept was given using recombinant bacterio-
phage phi11 lysin (Sass & Bierbaum, 2007). As a prophy-
lactic measure, PlyC endolysin significantly reduced
Streptococcus equi (Hoopes et al., 2009). Ply3626 has
been proposed as an agent to control the C. perfringens
population by direct addition to food, raw products and
feed, to fight the development of this pathogen in intestines
of poultry (Zimmer et al., 2002). In a study, aiming toselectively protect dairy products, Gaeng et al. examined
the possibility to recombinantly introduce an endolysin
gene in Lactococcus lactis. Their work resulted in the pro-
duction of dairy starter cultures with biopreservation prop-
erties against L. monocytogenes contaminations (Gaeng
et al., 2000). Regarding mastitis control programs, bacterio-
phage lysin Ply700 was shown to kill S. uberis in milk, but
more tests are needed to determine its efficiency on control-
ling S. uberis mastitis (Celia et al., 2008). Finally, Zhang
and coworkers found that the endolysin LysZ5 from the
L. monocytogenes phage FWLLm3 was able to reduce
Listerial contamination in soya milk at refrigeration tem-
peratures (4 C) (Zhang et al., 2012).
In food processing environments, more particularly in
dairy manufacturing, work has been developed in an at-
tempt to kill S. aureus in pasteurized milk using staphylo-
coccal phage endolysin LysH5 (Obeso et al., 2008). In
fermented products, endolysins can be used to avoid con-
tamination in starter cultures. Mayer and colleagues
showed the potential of the CTP1 endolysin to control
late blowing during cheese fermentation without affecting
the fermentation microbiota (Mayer et al., 2010). On a dif-
ferent approach, a L. lactis endolysin expression system
was created to accelerate cheese ripening (de Ruyter,
Kuipers, Meijer, & de Vos, 1997).
Table 2. Summary of in situ or possible endolysins food-based applications.
Targeted pathogen Endolysin Sample matrix (aim) Outcome/reducing effect Refs.
E. carotovora T4 lysozyme Transgenic potatoes Endolysin secretion in transgenic
potato plants effects a resistance
against E. carotovora at low expression
levels
(During et al., 1993)
E. amylovora phiEalh lysin Pears surface Ooze formation and necrosis were
retarded or inhibited after inoculation
with E. amylovora
(Kim et al., 2004)
S. aureus phi11 lysin Bovine milk (aim) Up to 2 log reduction on coagulase-
negative staphylococcus
(Donovan, Lardeo,
et al., 2006)
S. equi PlyC lysin Horse-related material
surfaces
Aerosolized PlyC could sterilized 7 of
8 common stable equipment
(Hoopes et al., 2009)
C. perfringens Phi3626 lysin Poultry intestines (aim) Active to all 48 C. perfringens strains
tested, not affecting other clostridia
and bacteria belonging to other genera
(Zimmer et al., 2002)
L. monocytogenes Ply511 lysin Milk fermentation (aim) Possibility to secrete an active Listeria
endolysin although their antagonistic
activity has not been assessed
(Gaeng et al., 2000)
S. uberis Ply700 lysin Bovine milk Ply700 (50 mg/ml) killed 81% of
S. uberis in milk
(Celia et al., 2008)
S. aureus LysH5 lysin Pasteurized milk The addition of 160 U/ml (88 mg/ml) of
LysH5 to pasteurized milk reduced the
viable counts to undetectable levels in
4 h
(Obeso et al., 2008)
C. tyrobutyricum phiCTP1 lysin Semi-skim milk One log reduction unit (Mayer et al., 2010)
L. lactis phiUS3 lysin/holin Cheese milk Fourfold increase in release of
L-Lactate dehydrogenase activity
contributing for accelerate cheese
ripening
(de Ruyter et al., 1997)
L. monocytogenes CBD118 and
CBD500
Meat, poultry, fish, dairy
and ready-to-eat products
Listeria separation from food samples
using CBDs revealed to more sensitive
and less time consuming (only 48 h
versus 96 h) from standardized
methods
(Kretzer et al., 2007)
L. monocytogenes CBDP40 Milk and cheese Cells from different Listeria strains
were removed and identified from
food samples
(Schmelcher et al.,
2010)
L. monocytogenes CBDP40 Milk and cheese Cells from different Listeria strains
were removed and identified from
food samples
(Schmelcher et al.,
2010)
L. monocytogenes Lys Soya milk More than 4 logs reduction after 3 h
incubation at refrigerated temperature
(4 C)
(Zhang et al., 2012)
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bacteria, endolysins can be further used as identification
and capture systems (Fujinami et al., 2007). In this context,
high immobilization and removal of L. monocytogenes
from artificially and naturally contaminated samples was
achieved using a CBD-based magnetic separation method
(Kretzer et al., 2007). Relying on their high efficiency,
even different Listeria strains could be recovered from
milk and cheese using a CBD cocktail with different fluo-
rescent markers (Schmelcher et al., 2010).
Resistant Gram-negative foodborne bacteria
So far, the main target for endolysins in food systems
has been Gram-positive microorganisms, mostly because
of their enhanced susceptibility to endolysins due to the
lack of a protective outer membrane. Since foodborne con-
taminations are mostly caused by Gram-negative bacteria,and in view of their conserved PGN structure, the applica-
tion of lysins on these bacteria is considered to be the “holy
grail” in endolysin control of foodborne bacteria. Possible
strategies that can be foreseen to sensitize Gram-negative
bacteria are outer membrane permeabilization using physi-
cal processing, the use of outer membrane permeabilizing
compounds or the covalent modification of endolysins.
Although permeabilization agents have been extensively
reviewed by Vaara (Vaara, 1992), so far only one successful
study using an EDTA treatment coupled with the endolysin
EL188 to control P. aeruginosa cells has been reported.
The addition of short hydrophobic amino acids motifs, pre-
dicted to target the outer membrane bilayer, constitutes
a promising strategy to lyse Gram-negative bacteria. It
was found that both Bacillus amyloliquefaciens phage lysin
and the Acinetobacter baumannii phage lysin LysAB2 har-
bor a similar amino acid group, responsible for the passage
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Gram-negative cells (Lai et al., 2011; Morita et al., 2001;
Orito, Morita, Hori, Unno, & Tanji, 2004). Therefore it is
plausible that selected endolysins could genetically be
fused to such peptides to target Gram-negative microorgan-
isms. Finally, non-thermal treatments can be used in syn-
ergy with endolysins to contribute to food stabilization
and shelf-life prolongation. The use of high hydrostatic
pressure was shown to permeabilize the cells’ outer mem-
brane in order for phage lysins to become active against
Gram-negative bacteria (Briers et al., 2008).
General conclusions and future perspectives
In view of the current need to control outbreaks of food-
borne pathogens, endolysin-based strategies have revealed
to be highly efficient in eliminating microorganisms, merit-
ing their position in the class of new food antimicrobials.
Phages outnumber the total amount of bacteria, and there-
fore a high amount of phages (and with it a reservoir of ly-
sins) on Earth are yet to be discovered. It is expected that
for each existing pathogenic bacterium a lysin will be
found. However, their application should be carefully stud-
ied, as they may not be active in all types of food systems of
varied environments. To understand the full potential of
these enzymes on modern food enzyme technology, it is
important to study real processing conditions on more com-
plex and coordinated enzyme-mediated processes. Also, the
more impermeable Gram-negative bacteria deserve particu-
lar attention with regard to endolysin application. With Sal-
monella and Campylobacter spp being the two most
occurring foodborne pathogens, the development of newly
isolated, engineered or tailor-made endolysins toward these
pathogens will provide new application possibilities.
It is prudent to stress safety issues for the acceptance by
food regulatory entities and the final consumer, as far as en-
dolysin application on foodstuff is concerned. Nevertheless,
the unique characteristics of endolysins warrant their use as
promising novel biocontrol entities in the battle to prevent
foodborne infections and to safeguard food quality.
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